858 related articles for article (PubMed ID: 30089583)
1. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment.
Hirayama S; Ishii G; Nagai K; Ono S; Kojima M; Yamauchi C; Aokage K; Hishida T; Yoshida J; Suzuki K; Ochiai A
J Thorac Oncol; 2012 Dec; 7(12):1790-1797. PubMed ID: 23154550
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry.
Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK
Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162
[TBL] [Abstract][Full Text] [Related]
4. CC-Chemokine Ligand 18 Is an Independent Prognostic Marker in Lymph Node-positive Non-small Cell Lung Cancer.
Schmid S; Csanadi A; Kozhuharov N; Tchudjin M; Kayser C; Rawluk J; Passlick B; Werner M; Prasse A; Kayser G
Anticancer Res; 2018 Jul; 38(7):3913-3918. PubMed ID: 29970512
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Associated CD204-Positive Macrophage Is a Prognostic Marker in Clinical Stage I Lung Adenocarcinoma.
Sun Y; Xu S
Biomed Res Int; 2018; 2018():8459193. PubMed ID: 29850577
[TBL] [Abstract][Full Text] [Related]
6. Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer.
Jackute J; Zemaitis M; Pranys D; Sitkauskiene B; Miliauskas S; Vaitkiene S; Sakalauskas R
BMC Immunol; 2018 Jan; 19(1):3. PubMed ID: 29361917
[TBL] [Abstract][Full Text] [Related]
7. CD163
Kubota K; Moriyama M; Furukawa S; Rafiul HASM; Maruse Y; Jinno T; Tanaka A; Ohta M; Ishiguro N; Yamauchi M; Sakamoto M; Maehara T; Hayashida JN; Kawano S; Kiyoshima T; Nakamura S
Sci Rep; 2017 May; 7(1):1755. PubMed ID: 28496107
[TBL] [Abstract][Full Text] [Related]
8. The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer.
Dai F; Liu L; Che G; Yu N; Pu Q; Zhang S; Ma J; Ma L; You Z
BMC Cancer; 2010 May; 10():220. PubMed ID: 20487543
[TBL] [Abstract][Full Text] [Related]
9. Antibody combinations for optimized staining of macrophages in human lung tumours.
Frafjord A; Skarshaug R; Hammarström C; Stankovic B; Dorg LT; Aamodt H; Woldbaek PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
Scand J Immunol; 2020 Jul; 92(1):e12889. PubMed ID: 32299134
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer.
Chung FT; Lee KY; Wang CW; Heh CC; Chan YF; Chen HW; Kuo CH; Feng PH; Lin TY; Wang CH; Chou CL; Chen HC; Lin SM; Kuo HP
Int J Cancer; 2012 Aug; 131(3):E227-35. PubMed ID: 22174092
[TBL] [Abstract][Full Text] [Related]
11. Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
Sakai T; Aokage K; Neri S; Nakamura H; Nomura S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Iyoda A; Tsuboi M; Ishii G
Lung Cancer; 2018 Dec; 126():64-71. PubMed ID: 30527194
[TBL] [Abstract][Full Text] [Related]
12. Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma.
Ohtaki Y; Ishii G; Nagai K; Ashimine S; Kuwata T; Hishida T; Nishimura M; Yoshida J; Takeyoshi I; Ochiai A
J Thorac Oncol; 2010 Oct; 5(10):1507-15. PubMed ID: 20802348
[TBL] [Abstract][Full Text] [Related]
13. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
14. Low density of CD204-positive M2-type tumor-associated macrophages in Epstein-Barr virus-associated gastric cancer: a clinicopathologic study with digital image analysis.
Ichimura T; Abe H; Morikawa T; Yamashita H; Ishikawa S; Ushiku T; Seto Y; Fukayama M
Hum Pathol; 2016 Oct; 56():74-80. PubMed ID: 27342912
[TBL] [Abstract][Full Text] [Related]
15. Interstitial tumor-associated macrophages combined with tumor-derived colony-stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non-small cell lung cancer.
Pei BX; Sun BS; Zhang ZF; Wang AL; Ren P
J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1208-1216.e2. PubMed ID: 24907005
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma.
Ito M; Ishii G; Nagai K; Maeda R; Nakano Y; Ochiai A
Chest; 2012 Jul; 142(1):151-158. PubMed ID: 22302300
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
[TBL] [Abstract][Full Text] [Related]
18. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time.
Ma J; Liu L; Che G; Yu N; Dai F; You Z
BMC Cancer; 2010 Mar; 10():112. PubMed ID: 20338029
[TBL] [Abstract][Full Text] [Related]
19. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
Medrek C; Pontén F; Jirström K; Leandersson K
BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis.
Mei J; Xiao Z; Guo C; Pu Q; Ma L; Liu C; Lin F; Liao H; You Z; Liu L
Oncotarget; 2016 Jun; 7(23):34217-28. PubMed ID: 27144518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
